You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III small lymphocytic lymphoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Nagoya-shi, Aichi, Japan
  • +19 more
Jan 25, 2023

Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

Recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • +6 more
  • Beijing, China
    Beijing Cancer Hospital
Feb 6, 2023

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Rochester, New York
    University of Rochester
Feb 7, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

Not yet recruiting
  • Stage III NSCLC
  • Surgery
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Feb 21, 2023

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

Enrolling by invitation
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • 5:2 Method (intermittent fasting regimen)
  • 16/8 Method (intermittent fast regimen)
  • Victoria, British Columbia, Canada
    Eleah Stringer
Feb 2, 2023

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Monterey, California
  • +4 more
Aug 29, 2022

Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)

Completed
  • Small Lymphocytic Lymphoma
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +5 more
Jul 11, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Acute Side Effects In Stage III NSCLC With Definitive CRT

Completed
  • Non-small Cell Lung Cancer Stage III
    • Ankara, Turkey
      Ankara University Medicine School Radiation Oncology
    Aug 22, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Obinutuzumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Boston, Massachusetts
    • +17 more
    Aug 1, 2022

    Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Completed
    • Loss of Chromosome 17p
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
    • +11 more
    Nov 23, 2022

    Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance

    Active, not recruiting
    • Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
      • Aichi, Japan
      • +48 more
      Dec 7, 2022

      Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

      Suspended
      • Recurrent Aggressive Non-Hodgkin Lymphoma
      • +5 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 12, 2023

      Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 20, 2023

      Lung Cancer Stage III Trial (ctDNA)

      Not yet recruiting
      • Lung Cancer Stage III
      • ctDNA
      • (no location specified)
      Oct 26, 2023

      Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma

      Completed
      Has Results
      • Follicular Lymphoma (FL/Indolent NHL)
      • +4 more
      • Huntsville, Alabama
      • +22 more
      Apr 1, 2022

      Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

      Completed
      • Lymphoid Leukemia
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin
      Jan 30, 2023

      Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Miami (Acalabrutinib,

      Terminated
      Has Results
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • Miami, Florida
        University of Miami
      Aug 23, 2022

      Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

      Completed
      • Grade 3a Follicular Lymphoma
      • +9 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 31, 2023

      Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

      Recruiting
      • Nonsmall Cell Lung Cancer
      • +3 more
      • Genomically Guided Radiation Therapy (RT)
      • Tampa, Florida
        Moffitt Cancer Center
      May 23, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma Trial in Worldwide (BMS-986403, Fludarabine, Cyclophosphamide)

      Recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Lymphoma
      • Birmingham, Alabama
      • +24 more
      Jul 6, 2022

      Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

      Withdrawn
      • Chronic Lymphocytic Leukemia
      • +8 more
      • Dose combination 1-1
      • +5 more
      • (no location specified)
      Nov 1, 2021

      Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

      Not yet recruiting
      • Autoimmune Hemolytic Anemia
      • +3 more
      • Ibrutinib 420 mg
      • (no location specified)
      Jan 12, 2023